Transport properties of dense deuterium-tritium plasmas

Consistent descriptions of the equation of states, and information about transport coefficients of deuterium-tritium mixture are demonstrated through quantum molecular dynamic (QMD) simulations (up to a density of 600 g/cm$^{3}$ and a temperature of $10^{4}$ eV). Diffusion coefficients and viscosity are compared with one component plasma model in different regimes from the strong coupled to the kinetic one. Electronic and radiative transport coefficients, which are compared with models currently used in hydrodynamic simulations of inertial confinement fusion, are evaluated up to 800 eV. The Lorentz number is also discussed from the highly degenerate to the intermediate region.Comment: 4 pages, 3 figure

(E)-2-(4-Diethyl­amino-2-hydroxy­benzyl­idene­amino)benzonitrile

The mol­ecule of the title compound, C18H19N3O, displays a trans configuration with respect to the C=N double bond. The dihedral angle between the planes of the two benzene rings is 2.62 (11)°. A strong intra­molecular O—H⋯N hydrogen bond stabilizes the mol­ecular conformation

3β-Acet­oxy-8β,10β-dihy­droxy-6β-meth­oxy­eremophil-7(11)-en-8,12-olide

The title compound, C18H26O7, is an eremophilenolide which has been isolated from the plant Ligularia duciformis for the first time. The present study confirms the atomic connectivity assigned on the basis of 1H and 13C NMR spectroscopy. The mol­ecule contains three fused rings, two six-membered rings in chair confomations and a five-membered ring in a flattened envelope conformation. Two hy­droxy groups are involved in formation of intra- and inter­molecular O—H⋯O hydrogen bonds. The latter ones link mol­ecules into chains propagating in [010]

Construction of Novel Nanocomposites (Cu-MOF/GOD@HA) for Chemodynamic Therapy

The emerging chemodynamic therapy (CDT) has received an extensive attention in recent years. However, the efficiency of CDT is influenced due to the limitation of H2O2 in tumor. In this study, we designed and synthesized a novel core-shell nanostructure, Cu-metal organic framework (Cu-MOF)/glucose oxidase (GOD)@hyaluronic acid (HA) (Cu-MOF/GOD@HA) for the purpose of improving CDT efficacy by increasing H2O2 concentration and cancer cell targeting. In this design, Cu-MOF act as a CDT agent and GOD carrier. Cu(II) in Cu-MOF are reduced to Cu(I) by GSH to obtain Cu(I)-MOF while GSH is depleted. The depletion of GSH reinforces the concentration of H2O2 in tumor to improve the efficiency of CDT. The resultant Cu(I)-MOF catalyze H2O2 to generate hydroxyl radicals (·OH) for CDT. GOD can catalyze glucose (Glu) to supply H2O2 for CDT enhancement. HA act as a targeting molecule to improve the targeting ability of Cu-MOF/GOD@HA to the tumor cells. In addition, after loading with GOD and coating with HA, the proportion of Cu(I) in Cu-MOF/GOD@HA is increased compared with the proportion of Cu(I) in Cu-MOF. This phenomenon may shorten the reactive time from Cu-MOF to Cu(I)-MOF. The CDT enhancement as a result of GOD and HA effects in Cu-MOF/GOD@HA was evidenced by in vitro cell and in vivo animal studies

3a,11b-Dihy­droxy-3a,11b-dihydro-1H-imidazo[4,5-f][1,10]phenanthroline-2(3H)-thione

The title compound, C13H10N4O2S, was prepared through a cyclization reaction of 1,10-phenanthroline-5,6-dione and thio­urea. The dihedral angle between the pyridine rings is 8.22 (2)°. In the crystal, mol­ecules are connected by N—H⋯O, O—H⋯N, N—H⋯S and O—H⋯S hydrogen bonds, forming a three-dimensional network